Literature DB >> 6332078

Electron microscopic study showing antibody-independent binding of C1q, a subcomponent of the first component of complement, to serum-sensitive salmonellae.

F Clas, J R Golecki, M Loos.   

Abstract

Effective serum-mediated killing of sensitive gram-negative bacteria requires all the complement components. In the preimmune phase the antibody-independent interaction of the first component of complement, C1, with the bacteria might be especially important. Electron microscopic studies showed that the C1 subcomponent C1q binds only to the serum-sensitive R form of Salmonella minnesota and not to the serum-resistant S form.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332078      PMCID: PMC263372          DOI: 10.1128/iai.45.3.795-797.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Freeze-etching nomenclature.

Authors:  D Branton; S Bullivant; N B Gilula; M J Karnovsky; H Moor; K Mühlethaler; D H Northcote; L Packer; B Satir; P Satir; V Speth; L A Staehlin; R L Steere; R S Weinstein
Journal:  Science       Date:  1975-10-03       Impact factor: 47.728

2.  Interaction of the first (C1), the second (C2) and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A.

Authors:  M Loos; D Bitter-Suermann; M Dierich
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

3.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).

Authors:  D C Morrison; L F Kline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

4.  Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesota.

Authors:  F Clas; M Loos
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

5.  Antibody-independent interaction of the first component of complement with Gram-negative bacteria.

Authors:  M Loos; B Wellek; R Thesen; W Opferkuch
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

6.  Antibody-independent interactions between Escherichia coli J5 and human complement components.

Authors:  S J Betz; H Isliker
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

7.  Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.

Authors:  F Clas; M Loos
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

8.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

9.  Staining of tissue sections for electron microscopy with heavy metals.

Authors:  M L WATSON
Journal:  J Biophys Biochem Cytol       Date:  1958-07-25

10.  Electron microscope study of DNA-containing plasms. II. Vegetative and mature phage DNA as compared with normal bacterial nucleoids in different physiological states.

Authors:  E KELLENBERGER; A RYTER; J SECHAUD
Journal:  J Biophys Biochem Cytol       Date:  1958-11-25
View more
  4 in total

1.  Role of C1q in phagocytosis of Salmonella minnesota by pulmonary endothelial cells.

Authors:  U S Ryan; D R Schultz; J D Goodwin; J M Vann; M P Selvaraj; M A Hart
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

2.  Antibody-independent interactions of fibronectin, C1q, and human neutrophils with Treponema pallidum.

Authors:  R E Baughn
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

3.  Solid-phase C1q-directed bacterial capture followed by PCR for detection of Chlamydia trachomatis in clinical specimens.

Authors:  P Herbrink; H A van den Munckhof; H G Niesters; W H Goessens; E Stolz; W G Quint
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

4.  C1q, a subunit of the first component of complement, enhances binding of plasma fibronectin to bacteria.

Authors:  J M Sorvillo; E Pearlstein
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.